This first German evidence-based guideline for cutaneous melanoma was developed under
the auspices of the German Dermatological Society (DDG) and the Dermatologic …

OBJECTIVES: To investigate the volumetric iodine-uptake (VIU) changes by dual-energy
CT (DECT) in assessing the response to sorafenib treated hepatocellular carcinoma (HCC) …

RATIONALE AND OBJECTIVES: To evaluate whether dynamic computed tomography (CT)-imaging
can provide functional vessel information in patients with chronic aortic dissection …

Rationale and objectives To detect distensibility changes that might be an indicator for an
increased risk of rupture, cross-sectional area changes of abdominal aortic aneurysms (AAA) …

Purpose Photon-based radiation therapy does currently not play a major role as local ablative
treatment for hepatocellular carcinoma (HCC). Carbon ions offer distinct physical and …

The aim of the S3-guideline melanoma contains recommendations on diagnosis, therapy and
follow-up of cutaneous melanoma in its primary, limited locoregional and metastatic stages…

Purpose: Thanks to advances in cancer therapy, the diagnosis of “incurable cancer” is
increasingly able to be changed to a chronic disease that is manageable over long periods, …

Purpose: The aim of this study was to characterize and understand the therapy-induced
changes in diffusion parameters in rectal carcinoma under chemoradiotherapy (CRT). The …

Objectives: To evaluate hemodynamic changes during aneurysmal dilatation in chronic type
B aortic dissections compared to hemodynamic parameters in the healthy aorta with the use …

Objective: To date, sorafenib is the only approved systemic therapy for advanced hepatocellular
carcinoma (HCC). Pancreatic atrophy has recently been reported in 2 patients as a …